Verus Capital Partners’s VivoSim Labs VIVS Stock Holding History

Verus Capital Partners’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4	Closed	–	–	1612
2019 Q4	$0	Buy	+4	New	+$374	﹤0.01%	1554

Other funds holding VIVS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Verus Capital Partners's VIVS Position: Q1 2020 in Review

Verus Capital Partners sold out of VivoSim Labs (VIVS) in Q1 2020, closing a stake of 4 shares.

Verus Capital Partners first reported a position in VIVS in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 75 funds tracked by Wall St. Rank hold VIVS as of Q1 2020.

Verus Capital Partners reported no remaining VivoSim Labs position as of Q1 2020 after selling out during the quarter.
Verus Capital Partners sold 4 VivoSim Labs shares in Q1 2020.
Verus Capital Partners first reported a position in VivoSim Labs in Q4 2019 and held it in 1 quarter.
Verus Capital Partners's VivoSim Labs position peaked at $0 in Q4 2019.
75 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.